Indraprastha Medical Corporation Ltd
Indraprastha Medical Corporation Ltd (INDRAMEDCO) last reported results for the quarter ended Jun 2026, with sales of ₹406 crore and net profit of ₹56 crore. The stock last traded at ₹331, a market capitalisation of ₹3,033 crore, on a P/E of 16.2. Over the past 52 weeks the stock has ranged between ₹330 and ₹641. Figures are as of 6 Oct 2026 and are not real time.
Indraprastha Medical Corporation Ltd share price and key metrics
- Current price
- ₹331
- Market cap
- ₹3,033 cr
- Stock P/E
- 16.2
- Book value
- ₹80.8
- ROE
- 27.4%
- ROCE
- 35.8%
- Dividend yield
- 1.22%
- 52w high / low
- 641/330
Metrics as of 6 Oct 2026. Not real time.
Track Indraprastha Medical Corporation Ltd
Cruxal reads every Indraprastha Medical Corporation Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Indraprastha Medical Corporation Ltd growth and returns
- 10 Years
- 7%
- 5 Years
- 19%
- 3 Years
- 11%
- TTM
- 11%
- 10 Years
- 22%
- 5 Years
- 132%
- 3 Years
- 28%
- TTM
- 12%
- 10 Years
- 20%
- 5 Years
- 33%
- 3 Years
- 24%
- 1 Year
- -30%
- 10 Years
- 21%
- 5 Years
- 27%
- 3 Years
- 29%
- Last Year
- 27%
Indraprastha Medical Corporation Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹406 cr, up 11.2% from ₹365 cr a year earlier. Net profit was ₹56 cr, up 9.8% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 350 | 325 | 334 | 365 | 381 | 372 | 365 | 406 |
| Expenses | 286 | 273 | 272 | 292 | 310 | 310 | 304 | 326 |
| Operating profit | 64 | 52 | 61 | 73 | 71 | 62 | 61 | 80 |
| OPM % | 18% | 16% | 18% | 20% | 19% | 17% | 17% | 20% |
| Other income | 6 | 5 | 6 | 7 | 7 | 7 | 7 | 8 |
| Interest | 2 | 2 | 1 | 2 | 2 | 1 | 1 | 2 |
| Depreciation | 11 | 11 | 11 | 10 | 11 | 11 | 11 | 12 |
| Profit before tax | 57 | 45 | 55 | 68 | 66 | 56 | 55 | 75 |
| Tax % | 26% | 26% | 26% | 25% | 25% | 27% | 24% | 25% |
| Net profit | 42 | 33 | 41 | 51 | 49 | 41 | 42 | 56 |
| EPS (₹) | 4.63 | 3.58 | 4.47 | 5.61 | 5.40 | 4.47 | 4.55 | 6.09 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Indraprastha Medical Corporation Ltd annual results
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 766 | 753 | 788 | 831 | 613 | 888 | 1,099 | 1,245 | 1,356 | 1,483 | 1,524 |
| Operating profit | 79 | 74 | 82 | 87 | 41 | 120 | 152 | 195 | 245 | 267 | 274 |
| OPM % | 10% | 10% | 10% | 11% | 7% | 14% | 14% | 16% | 18% | 18% | 18% |
| Net profit | 26 | 21 | 28 | 44 | 2 | 59 | 86 | 124 | 161 | 184 | 188 |
| EPS (₹) | 2.86 | 2.30 | 3.10 | 4.76 | 0.25 | 6.39 | 9.40 | 13.52 | 17.56 | 20.03 | 20.51 |
TTM is the trailing twelve months to the most recent quarter.
Indraprastha Medical Corporation Ltd balance sheet
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 92 | 92 | 92 | 92 | 92 | 92 | 92 | 92 | 92 | 92 |
| Reserves | 139 | 141 | 152 | 176 | 181 | 234 | 288 | 386 | 505 | 649 |
| Borrowings | 67 | 66 | 21 | 4 | 3 | 5 | 2 | 34 | 33 | 37 |
| Other liabilities | 160 | 134 | 157 | 177 | 157 | 131 | 173 | 212 | 222 | 214 |
| Total liabilities | 458 | 432 | 422 | 449 | 432 | 462 | 555 | 723 | 852 | 991 |
| Fixed assets | 296 | 294 | 280 | 303 | 283 | 277 | 275 | 347 | 328 | 365 |
| CWIP | 0 | 0 | 1 | 0 | 3 | 0 | 3 | 0 | 33 | 3 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other assets | 163 | 138 | 141 | 146 | 145 | 185 | 278 | 376 | 491 | 624 |
| Total assets | 458 | 432 | 422 | 449 | 432 | 462 | 555 | 723 | 852 | 991 |
As reported by the company. Total assets equal total liabilities by construction.
Indraprastha Medical Corporation Ltd cash flow
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 28 | 48 | 75 | 86 | 27 | 94 | 144 | 200 | 157 | 167 |
| Cash from investing | -22 | -30 | -17 | -40 | -19 | -74 | -108 | -158 | -111 | -178 |
| Cash from financing | -5 | -17 | -44 | -43 | -3 | -3 | -26 | -32 | -46 | -46 |
| Net cash flow | -0 | 1 | 14 | 4 | 5 | 17 | 11 | 9 | -0 | -57 |
| Free cash flow | 5 | 17 | 58 | 46 | 6 | 65 | 100 | 131 | 120 | 108 |
| CFO / operating profit | 57% | 82% | 110% | 113% | 88% | 95% | 102% | 127% | 89% | 88% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Indraprastha Medical Corporation Ltd operating ratios
| Per year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | 17% | 15% | 19% | 21% | 3% | 29% | 34% | 38% | 39% | 36% |
| Debtor days | 47 | 41 | 35 | 35 | 40 | 18 | 23 | 17 | 20 | 28 |
| Cash conversion cycle | 47 | 41 | 35 | 35 | 40 | 18 | 23 | 17 | 20 | 28 |
| Working capital days | -17 | -7 | -5 | -10 | -1 | -2 | -12 | -24 | -19 | -4 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Indraprastha Medical Corporation Ltd shareholding pattern
Promoters held 51.00% at Jun 2026, broadly unchanged since Jun 2025. FIIs 2.77% and DIIs 0.59%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 51.00% | 51.00% | 51.00% | 51.00% | 51.00% | 51.00% | 51.00% | 51.00% |
| FIIs | 2.64% | 2.88% | 2.94% | 2.73% | 2.41% | 2.72% | 2.43% | 2.77% |
| DIIs | 3.19% | 3.18% | 3.56% | 3.56% | 3.51% | 0.82% | 0.87% | 0.59% |
| Public | 43.16% | 42.91% | 42.50% | 42.74% | 43.08% | 45.43% | 45.69% | 45.65% |
| No. of shareholders | 64,671 | 69,697 | 70,491 | 70,211 | 70,914 | 71,225 | 72,980 | 75,098 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Indraprastha Medical Corporation Ltd corporate filings
- Indraprastha Medical Corporation Limited Announces Successful Conclusion of 38th AGM and Approval of INR 4.00 Per Share DividendAGM/EGMlow impact
Cruxal's analysis: Indraprastha Medical Corporation Limited has successfully concluded its 38th Annual…
Read the full analysis - Indraprastha Medical Corporation Limited concludes 38th AGM; declares dividend of INR 4.00 per shareAGM/EGMlow impact
Cruxal's analysis: Indraprastha Medical Corporation Limited has successfully concluded its 38th Annual…
Read the full analysis - The Trading Window for dealing in shares of the Company shall remain closed for all designated persons including Promoters, Directors, KMPs and other Designated Employee and their connected ....Insider Trading / SASTlow impact
- Indraprastha Medical Corporation Ltd publishes notice for transfer of shares to IEPFCompany Updatelow impact
Cruxal's analysis: Indraprastha Medical Corporation Ltd has published a public notice regarding the transfer…
Read the full analysis - Indraprastha Medical Corporation Limited announces 38th Annual General MeetingCompany Updatelow impact
Cruxal's analysis: Indraprastha Medical Corporation Limited has issued a public notice regarding its 38th…
Read the full analysis - Indraprastha Medical Corporation Ltd releases Annual Report and schedules 38th AGM for September 24, 2026Otherslow impact
Cruxal's analysis: Indraprastha Medical Corporation has filed its Annual Report for the financial year…
Read the full analysis - Indraprastha Medical Corporation Limited Announces FY 2025-26 Annual Report and Dividend of INR 4 per ShareAGM/EGMhigh impact
Cruxal's analysis: Indraprastha Medical Corporation Limited has released its Annual Report for FY 2025-26…
Read the full analysis - Indraprastha Medical Corporation Limited announces 38th AGM and dividend of INR 4.00 per share for FY 2025-26Company Updatelow impact
Cruxal's analysis: Indraprastha Medical Corporation Limited has scheduled its 38th Annual General Meeting…
Read the full analysis - Indraprastha Medical Corporation Limited reports Q1 FY2027 financial results with moderate revenue growth and stable profitabilityCompany Updatemedium impact
Cruxal's analysis: Indraprastha Medical Corporation Limited reported total income of 414.57 crore for the…
Read the full analysis - Indraprastha Medical Corporation Q1 FY27 Results: Revenue Grows 11.3% YoY to 406.15 Crore with Strong ProfitabilityBoard Meetinghigh impact
Cruxal's analysis: Indraprastha Medical Corporation Limited reported a strong performance for the quarter…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.